First ‐trimester exposure to tofacitinib in ulcerative colitis: A case report of a healthy newborn and literature review

We present a patient with ulcerative colitis on tofacitinib who had an unplanned pregnancy. Tofacitinib was ceased, switched to vedolizumab, and she gave birth to a healthy newborn at term. Case reports of reassuring outcomes provide real-world data that assists decision-making for future patients.
Source: Clinical Case Reports - Category: General Medicine Authors: Tags: CASE REPORT Source Type: research